Literature DB >> 15251426

Recombinant HMGB1 with cytokine-stimulating activity.

Jianhua Li1, Haichao Wang, James M Mason, Jacob Levine, Man Yu, Luis Ulloa, Christopher J Czura, Kevin J Tracey, Huan Yang.   

Abstract

We describe methods for the isolation, purification, and characterization of full-length high-mobility group box 1 (HMGB1) and truncated mutants expressed in bacteria and in mammalian Chinese Hamster Ovary (CHO) cells. HMGB1 is an abundant nuclear and cytoplasmic protein, highly conserved across species and widely distributed in eukaryotic cells from yeast to man. As a ubiquitous nuclear DNA binding protein, HMGB1 binds DNA, facilitates gene transcription, and stabilizes nucleosome structure. In addition to these intracellular roles, HMGB1 can be released into the extracellular milieu by activated innate immune cells (i.e., macrophages, monocytes) and functions as a mediator of lethal endotoxemia and sepsis. The proinflammatory cytokine activity of HMGB1 has become an intense area of research and recombinant protein can be a useful tool to probe HMGB1 functions. Due to its dipolar charged properties, HMGB1 isolated by some methods can be contaminated with bacterial products (such as CpG DNA or lipopolysaccharide [LPS]) that may interfere with immunological analyses. Here we report our newly developed methods for the isolation and purification of biologically active HMGB1 from bacteria or mammalian CHO cells that is essentially free of contaminants. This strategy provides an important advance in methodology to facilitate future HMGB1 studies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15251426     DOI: 10.1016/j.jim.2004.04.019

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  66 in total

1.  Identification of hemopexin as an anti-inflammatory factor that inhibits synergy of hemoglobin with HMGB1 in sterile and infectious inflammation.

Authors:  Tian Lin; Fatima Sammy; Huan Yang; Sujatha Thundivalappil; Judith Hellman; Kevin J Tracey; H Shaw Warren
Journal:  J Immunol       Date:  2012-07-06       Impact factor: 5.422

Review 2.  HMGB1 release by inflammasomes.

Authors:  Lieselotte Vande Walle; Thirumala-Dev Kanneganti; Mohamed Lamkanfi
Journal:  Virulence       Date:  2011-03-01       Impact factor: 5.882

3.  Inhibition of high-mobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against Pseudomonas Aeruginosa pneumonia in cystic fibrosis.

Authors:  Maria Entezari; Daniel J Weiss; Ravikumar Sitapara; Laurie Whittaker; Matthew J Wargo; JianHua Li; Haichao Wang; Huan Yang; Lokesh Sharma; Binh D Phan; Mohammad Javdan; Sangeeta S Chavan; Edmund J Miller; Kevin J Tracey; Lin L Mantell
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

Review 4.  The inflammatory response to cell death.

Authors:  Kenneth L Rock; Hajime Kono
Journal:  Annu Rev Pathol       Date:  2008       Impact factor: 23.472

5.  Chloroquine inhibits HMGB1 inflammatory signaling and protects mice from lethal sepsis.

Authors:  Minghua Yang; Lizhi Cao; Min Xie; Yan Yu; Rui Kang; Liangchun Yang; Mingyi Zhao; Daolin Tang
Journal:  Biochem Pharmacol       Date:  2013-05-22       Impact factor: 5.858

6.  Interaction of HMG proteins and H1 with hybrid PNA-DNA junctions.

Authors:  Filbert Totsingan; Anthony J Bell
Journal:  Protein Sci       Date:  2013-09-18       Impact factor: 6.725

Review 7.  Scientific and clinical challenges in sepsis.

Authors:  Luis Ulloa; Michael Brunner; Laura Ramos; Edwin A Deitch
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

8.  Proinflammatory Effects of Respiratory Syncytial Virus-Induced Epithelial HMGB1 on Human Innate Immune Cell Activation.

Authors:  Kempaiah Rayavara; Alexander Kurosky; Susan J Stafford; Nisha J Garg; Allan R Brasier; Roberto P Garofalo; Yashoda M Hosakote
Journal:  J Immunol       Date:  2018-10-01       Impact factor: 5.422

9.  Human HMGB1 directly facilitates interactions between nucleotide excision repair proteins on triplex-directed psoralen interstrand crosslinks.

Authors:  Sabine S Lange; Madhava C Reddy; Karen M Vasquez
Journal:  DNA Repair (Amst)       Date:  2009-05-14

10.  Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo.

Authors:  Marieke A D van Zoelen; Huan Yang; Sandrine Florquin; Joost C M Meijers; Shizuo Akira; Bernd Arnold; Peter P Nawroth; Angelika Bierhaus; Kevin J Tracey; Tom van der Poll
Journal:  Shock       Date:  2009-03       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.